Search clinical trials for: mixed dyslipidemia

Total 5796 results

National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Completed

Talampanel in Treating Patients With Recurrent High-Grade Glioma

Brain and Central Nervous System Tumors

United States
Fred Hutchinson Cancer Research Center/University...
National Cancer Institute (NCI)

Completed

Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications

Depression | Fatigue | Primary Myelofibrosis | Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone... and other conditions

United States
AstraZeneca

Completed

Centralized Pan-Russian Survey on the Undertreatment of Hypercholesterolemia (CEPHEUS)

Dyslipidaemia

Russian Federation
AstraZeneca

Completed

Observational Study to Estimate the Rates of Outcomes in Patients Undergoing Percutaneous Coronary Intervention (PCI) With Drug Eluting Stent (DES) Implantation Who Take Statins (OPTIMA)

Dyslipidemia | Coronary Heart Disease

Russian Federation
Takeda

Terminated

Safety Comparison of Pioglitazone and Glyburide in Type 2 Diabetes Subjects With Mild to Moderate Congestive Heart Failure

Diabetes Mellitus
Takeda
Eli Lilly and Company

Completed

Efficacy of Pioglitazone on Macrovascular Outcome in Patients With Type 2 Diabetes (PROactive)

Diabetes Mellitus

Estonia, Latvia, Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Hungary, Italy, Lithuania, Netherlands, Norway, Poland, Slovakia, Sweden, Switzerland, United Kingdom
Takeda

Completed

Efficacy of Pioglitazone on Microcirculation in Type 2 Diabetes Patients Treated With Insulin

Diabetes Mellitus

United Kingdom
Takeda
Eli Lilly and Company

Completed

Study to Compare Pioglitazone and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia

Diabetes Mellitus

United States
Takeda

Completed

Pioglitazone Study of Triglyceride Changes in Subjects With Type 2 Diabetes After Conversion From Rosiglitazone. (COMPLEMENT)

Diabetes Mellitus

United States, Puerto Rico
Takeda

Terminated

Safety and Efficacy of TAK-559 in Combination With Metformin in Patients With Type 2 Diabetes Mellitus.

Diabetes Mellitus
Takeda

Completed

Efficacy and Safety of Pioglitazone and Azilsartan in Treating Subjects With Type 2 Diabetes Mellitus

Diabetes Mellitus

United States, Argentina, Mexico, Peru, Chile
Takeda
Takeda Pharmaceuticals North America, Inc.

Completed

Efficacy of Pioglitazone Compared to Glyburide in Treating Subjects With Type 2 Diabetes Mellitus and Mild Cardiac Disease

Diabetes Mellitus
Takeda

Completed

Safety Study of Pioglitazone Compared To Glyburide on Liver Function

Diabetes Mellitus | Liver
Takeda

Completed

Efficacy Study of Pioglitazone and Glimepiride on the Rate of Progression of Atherosclerotic Disease. (CHICAGO)

Diabetes Mellitus

United States
Takeda

Completed

Efficacy Study of Pioglitazone Compared to Glimepiride on Coronary Atherosclerotic Disease Progression in Subjects With Type 2 Diabetes Mellitus (PERISCOPE)

Diabetes Mellitus

United States, Argentina, Canada, Chile
Takeda
Eli Lilly and Company

Completed

Observational Study to Assess Glycosylated Hemoglobin Changes After 6 Months of Treatment With Pioglitazone.

Diabetes Mellitus

Denmark, Iceland, Norway, Sweden
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Withdrawn

Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related Infection

Cancer
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Withdrawn

Procarbazine and Isotretinoin in Treating Patients With Recurrent Primary Malignant Gliomas

Brain and Central Nervous System Tumors
Lescuyer Laboratory
BioFortis

Completed

Effect of Limicol on (LDL)-Cholesterol Levels in Moderate Hypercholesterolaemia

Delivery of Health Care

France
AstraZeneca

Completed

Pattern of Statins Use in Catalonia

Hypercholesteremia
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Completed

Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia and Diffuse Non-Hodgkin's Lymphoma

Lymphoma | Leukemia

United States, Egypt, India
Pfizer

Terminated

Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Subjects With A Genetic Cholesterol Disorder.

Hyperlipoproteinemia Type III

Canada, United States
Pfizer

Completed

A Study of Torcetrapib/Atorvastatin vs Atorvastatin Alone or Placebo in Patients With High Cholesterol

Hyperlipidemia

United States, Germany, Norway, Belgium, Korea, Republic of, Mexico, Sweden, United Kingdom
Pfizer

Terminated

A Clinical Trial Comparing Torcetrapib/Atorvastatin To Simvastatin In Subjects With High Cholesterol (A5091031).

Dyslipidemia | Hypercholesterolemia | Hyperlipidemia

United States
Indonesia University

Completed

Effect of Nigella Sativa on Lipid Profiles in Elderly

Dyslipidemia

Indonesia
Otologics LLC

Unknown

Middle-Ear Implant With MET V Transducer (Aka MET V System)

Mixed Conductive and Sensorineural Hearing Loss, Bilateral
Unilever R&D

Completed

Efficacy Study on the Lipid-lowering Effect of Plant Sterols and Fish Oil

Healthy | Mildly Elevated Cholesterol Levels

Sweden
Takeda

Completed

Study of Alogliptin Combined With Sulfonylurea in Subjects With Type 2 Diabetes Mellitus.

Diabetes Mellitus

United States, Australia, Brazil, Chile, Guatemala, India, Mexico, New Zealand, Peru, South Africa, Netherlands, Poland, United Kingdom, Argentina, Dominican Republic
Bastyr University
University of Washington

Completed

Feeding the Rainbow to Investigate Endothelial Dysfunction (FRIED)

Cardiovascular Disease | Dietary Modification

United States
Takeda

Completed

Efficacy and Safety of Alogliptin Combined With Metformin in Participants With Type 2 Diabetes Mellitus

Diabetes Mellitus

United States, Australia, Brazil, Chile, Guatemala, India, Mexico, New Zealand, Peru, South Africa, Czech Republic, Germany, Hungary, Netherlands, Poland, United Kingdom, Argentina
Takeda

Completed

Efficacy and Safety Study of Alogliptin and Insulin in the Treatment of Type 2 Diabetes.

Diabetes Mellitus

United States, Australia, Brazil, Chile, Guatemala, India, Mexico, New Zealand, Peru, South Africa, Czech Republic, Germany, Hungary, Netherlands, Poland, Argentina
Takeda

Completed

Study of Alogliptin Combined With Pioglitazone in Subjects With Type 2 Diabetes Mellitus

Diabetes Mellitus

United States, Australia, Brazil, Guatemala, India, Mexico, New Zealand, Peru, South Africa, Czech Republic, Germany, Hungary, Netherlands, Argentina
Takeda

Completed

Efficacy and Safety of Alogliptin in Subjects With Type 2 Diabetes

Diabetes Mellitus

United States, Australia, Brazil, Chile, Guatemala, India, Mexico, New Zealand, Peru, South Africa, Czech Republic, Germany, Hungary, Netherlands, Poland, United Kingdom, Argentina, Dominican Republic
Takeda

Terminated

Efficacy and Safety of TAK-559 Combined With Glyburide in Treating Subjects With Type 2 Diabetes Mellitus. (ORIGAMI)

Diabetes Mellitus
Medco Health Solutions, Inc.
Celera Genomics

Completed

Additional KIF6 Risk Offers Better Adherence to Statins (AKROBATS)

Cardiovascular Diseases | Dyslipidemia

United States
Santaris Pharma A/S

Completed

Multiple Ascending Dose Study of SPC4955 in Healthy Subjects

Hypercholesterolemia

Germany
Afexa Life Sciences Inc

Completed

LIP-01 in Hypercholesterolemia

Hypercholesterolemia

Canada, United States
McMaster University

Completed

A Pilot Study Evaluating a Multidisciplinary Chronic Pain Group Therapy in a Primary Care Setting (LEAP)

Chronic Pain

Canada
Universita di Verona

Unknown

Mechanisms of Atherogenesis During Post-prandial Time in Childhood Obesity

Inflammation | Insulin Resistance | Childhood Obesity | Endothelial Dysfunction

Italy
AstraZeneca

Completed

Efficiency of Rosuvastatin Versus the Fixed Combination of Ezetimibe/Simvastatin in Outpatients

Dyslipidemia

Mexico
Daiichi Sankyo, Inc.

Terminated

Efficacy and Safety of the ACAT Inhibitor CS-505 (Pactimibe) for Reducing the Progression of Carotid Artery Disease. This Study is Also Known as CAPTIVATE.

Atherosclerosis | Heterozygous Familial Hypercholesterolemia

United States, United Kingdom, Spain, South Africa, Israel, Canada, Netherlands, Norway, Sweden
Enzymotec

Completed

Effect of Plant Sterols Esterified to Fish Oil Fatty Acids on Plasma Lipid Levels

Dyslipidemia

Israel
MetaProteomics LLC
University of Florida; University of California, Irvine; University of Connecticut

Completed

Trial of Two Dietary Programs on Cardiometabolic Risk Factors in Subjects With Metabolic Syndrome (HMS4)

Obesity | Overweight | Metabolic Syndrome | Hypercholesterolemia

United States
Promefarm S.r.l.

Completed

Evaluation of a Mixed Bowel Prep (2L PEG + Bisacodyl) Versus PEG With Ascorbate

Colonoscopy

Italy
University of California, Los Angeles
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Understanding the Genetic Basis of Familial Combined Hyperlipidemia in Mexican Individuals

Coronary Disease | Hyperlipidemia, Familial Combined

Mexico
Vanderbilt University
Fresenius Medical Care North America

Completed

Provision of Antioxidant Therapy in Hemodialysis (PATH) Study

End-stage Renal Disease

United States
GWT-TUD GmbH
Technische Universität Dresden; University of Regensburg

Completed

Efficacy of Nicotine Acid on Dyslipidaemia in Patients With Metabolic Syndrome

Metabolic Syndrome | Dyslipidaemia

Germany
University of Sydney

Completed

The Effect of a Nutritional Supplement in Individuals With Type 2 Diabetes Mellitus: a Pilot Study

Diabetes Mellitus, Type 2 | Insulin Resistance

Australia
Radiant Research

Completed

Colesevelam Treatment for Impaired Fasting Glucose During Niacin Therapy (CERTAIN)

Hyperglycemia | Dyslipidemia | Hyperlipidemia

United States
Norwegian University of Science and Technology

Completed

Endothelial Dysfunction Induced by Postprandial Lipemia

Healthy Subjects

Norway

Search clinical trials for: mixed dyslipidemia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Türkiye

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations